External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

AMCP 2024

-
Coming soon
03:00 PM
Duration 7hrs Los Angeles, USA
State-level opportunities for advancing biomarker testing in advanced non-small cell lung cancer (aNSCLC) patients with fully-insured commercial health plans
William Wong, Tu My To

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 90mins Los Angeles, USA
Estimates of Productivity Loss Due to Neurological Diseases in the United States
Julia Fox, Elizabeth Mearns, Thomas Majda, Kate Rosettie, Nikki Win, Stacey Kowal

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
03:30 PM
Duration 90mins Los Angeles, USA
Health resource utilization (HRU) in patients with multiple myeloma (MM) and cytogenetic abnormalities in the relapsed/refractory (R/R) setting: results using the Flatiron electronic health record (EHR) claims linked dataset
Li S, Wang R, Zafar F, Girvan A, Harton J, Banerjee R

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 90mins Los Angeles, USA
Management of Phosphoinositide 3-Kinase Inhibitor-Induced Hyperglycemia: A Targeted Literature Review
Bhatia N, Kim E, Cheng A, Du Toit Y

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar